Amedeo Smart

Free Medical Literature Service

 

Amedeo

Chronic Heart Failure
  Free Subscription

Articles published in
J Am Coll Cardiol
    April 2024
  1. BURCHILL LJ, Jain CC, Miranda WR
    Advancing New Solutions for Adult Congenital Heart Disease-Related Heart Failure.
    J Am Coll Cardiol. 2024;83:1415-1417.
    >> Share

  2. MARTON A, Saffari SE, Rauh M, Sun RN, et al
    Water Conservation Overrides Osmotic Diuresis During SGLT2 Inhibition in Patients With Heart Failure.
    J Am Coll Cardiol. 2024;83:1386-1398.
    >> Share

  3. NEIJENHUIS RML, MacDonald ST, Zemrak F, Mertens BJA, et al
    Effect of Sodium-Glucose Cotransporter 2 Inhibitors in Adults With Congenital Heart Disease.
    J Am Coll Cardiol. 2024;83:1403-1414.
    >> Share

  4. ACHANTA A, Belak L, Ritchie CS, Januzzi JL, et al
    Age-Related Usage of GLP-1 Agonists in Obese Patients With Heart Failure and Preserved Ejection Fraction.
    J Am Coll Cardiol. 2024;83:1348-1350.
    >> Share

  5. COSTANZO MR, Januzzi JL
    Early SGLT2 Inhibitors in Acute Heart Failure: Safe Diuretic-Sparing Strategy.
    J Am Coll Cardiol. 2024;83:1307-1309.
    >> Share

  6. COX ZL, Collins SP, Hernandez GA, McRae AT 3rd, et al
    Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure.
    J Am Coll Cardiol. 2024;83:1295-1306.
    >> Share

  7. COTTER G, Davison B, Chioncel O
    Enhanced Decongestive Therapy in Patients With Acute Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2024;83:1243-1252.
    >> Share

  8. UDELL JA, Petrie MC, Jones WS, Anker SD, et al
    Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial Infarction.
    J Am Coll Cardiol. 2024 Apr 1:S0735-1097(24)06757.
    >> Share

  9. CHATUR S, Neuen BL, Claggett BL, Beldhuis IE, et al
    Effects of Sacubitril/Valsartan Across the Spectrum of Renal Impairment in Patients With Heart Failure.
    J Am Coll Cardiol. 2024 Apr 1:S0735-1097(24)06691.
    >> Share

    March 2024
  10. ATALLAH B, Ghalib HH
    Pooling the NT-proBNP Benefits of ARNI: Fret the Index Hospitalization No More.
    J Am Coll Cardiol. 2024;83:1133-1135.
    >> Share

  11. MORROW DA, Velazquez EJ, Desai AS, DeVore AD, et al
    Sacubitril/Valsartan in Patients Hospitalized With Decompensated Heart Failure.
    J Am Coll Cardiol. 2024;83:1123-1132.
    >> Share

  12. GONZALEZ-LOPEZ E, McPhail ED, Salas-Anton C, Dominguez F, et al
    Histological Typing in Patients With Cardiac Amyloidosis: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2024;83:1085-1099.
    >> Share

  13. FOA A, Vaduganathan M, Claggett BL, Pabon MA, et al
    Sacubitril/Valsartan-Related Hypotension in Patients with Heart Failure and Preserved or Mildly Reduced Ejection Fraction.
    J Am Coll Cardiol. 2024 Mar 13:S0735-1097(24)00478.
    >> Share

  14. FUSTER V
    Editor-in-Chief's Top Picks From 2023.
    J Am Coll Cardiol. 2024;83:961-1026.
    >> Share

  15. HAGE C, Sundstrom J, Lund LH
    More evidence that heart failure with normal EF distinct from heart failure is below normal EF.
    J Am Coll Cardiol. 2024 Mar 12:S0735-1097(24)00990.
    >> Share

  16. NEWMAN JD, O'Meara E, Bohm M, Savarese G, et al
    Implications of Atrial Fibrillation for Guideline-Directed Therapy in Patients With Heart Failure: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2024;83:932-950.
    >> Share

  17. UDELL JA, Armstrong DWJ
    Targeting the Natriuretic Peptide System to Improve Outcomes: PARADISE Lost or Found.
    J Am Coll Cardiol. 2024;83:915-917.
    >> Share

  18. MANN DL, Nicolas J, Claggett B, Miao ZM, et al
    Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI.
    J Am Coll Cardiol. 2024;83:904-914.
    >> Share

  19. MADDOX TM, Januzzi JL Jr, Allen LA, Breathett K, et al
    2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee.
    J Am Coll Cardiol. 2024 Mar 2:S0735-1097(23)08354.
    >> Share

    February 2024
  20. BOTTINOR W, Im C, Doody DR, Armenian SH, et al
    Mortality After Major Cardiovascular Events in Survivors of Childhood Cancer.
    J Am Coll Cardiol. 2024;83:827-838.
    >> Share

  21. BARIANI R, Rigato I, Celeghin R, Marinas MB, et al
    Phenotypic Expression and Clinical Outcomes in Patients With Arrhythmogenic Cardiomyopathies.
    J Am Coll Cardiol. 2024;83:797-807.
    >> Share

  22. YOO JE, Kim M, Kim B, Lee H, et al
    Increased Risk of Myocardial Infarction, Heart Failure, and Atrial Fibrillation After Spinal Cord Injury.
    J Am Coll Cardiol. 2024;83:741-751.
    >> Share

  23. FUDIM M, Butler J, Kittipibul V
    Implantable Hemodynamic-GUIDE Monitors: A CHAMPION Among Devices for Heart Failure.
    J Am Coll Cardiol. 2024;83:695-698.
    >> Share

  24. LINDENFELD J, Costanzo MR, Zile MR, Ducharme A, et al
    Implantable Hemodynamic Monitors Improve Survival in Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2024;83:682-694.
    >> Share

  25. SCHUMACHER KR, Vitale C
    It Is Shocking How Little We Have Talked About Cardiogenic Shock in Pediatrics.
    J Am Coll Cardiol. 2024;83:609-610.
    >> Share

  26. PURI K, Jentzer JC, Spinner JA, Hope KD, et al
    Clinical Presentation, Classification, and Outcomes of Cardiogenic Shock in Children.
    J Am Coll Cardiol. 2024;83:595-608.
    >> Share

    January 2024
  27. CHHATRIWALLA AK, Cohen DJ, Vemulapalli S, Vekstein A, et al
    Transcatheter Edge-to-Edge Repair in COAPT-Ineligible Patients With Functional Mitral Regurgitation.
    J Am Coll Cardiol. 2024;83:488-499.
    >> Share

  28. TROLLE LAGERROS Y, Grotta A, Freyland S, Grannas D, et al
    Risk of Death in Patients With Coronary Artery Disease Taking Nitrates and Phosphodiesterase-5 Inhibitors.
    J Am Coll Cardiol. 2024;83:417-426.
    >> Share

  29. PACKER M
    Hyperuricemia and Gout Reduction by SGLT2 Inhibitors in Diabetes and Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2024;83:371-381.
    >> Share

  30. ALOGNA A, Berboth L, Faragli A, Otvos J, et al
    Lung-to-Heart Nano-in-Micro Peptide Promotes Cardiac Recovery in a Pig Model of Chronic Heart Failure.
    J Am Coll Cardiol. 2024;83:47-59.
    >> Share

    December 2023
  31. LAMBERT G, Chemello K, Gallo A
    Lipoprotein(a): More Than Just a Biomarker of Myocardial Fibrosis.
    J Am Coll Cardiol. 2023;82:2292-2295.
    >> Share

    November 2023
  32. VADUGANATHAN M, Ostrominski JW
    Glucagon-Like Peptide-1 Receptor Agonists in Heart Failure: STEPping Across the Ejection Fraction Divide.
    J Am Coll Cardiol. 2023;82:2097-2100.
    >> Share

  33. BUTLER J, Abildstrom SZ, Borlaug BA, Davies MJ, et al
    Semaglutide in Patients With Obesity and Heart Failure Across Mildly Reduced or Preserved Ejection Fraction.
    J Am Coll Cardiol. 2023;82:2087-2096.
    >> Share

  34. LOWERY MM, Hill NS, Wang L, Rosenzweig EB, et al
    Sleep-Related Hypoxia, Right Ventricular Dysfunction, and Survival in Patients With Group 1 Pulmonary Arterial Hypertension.
    J Am Coll Cardiol. 2023;82:1989-2005.
    >> Share

  35. BURGER PM, Visseren FLJ, Dorresteijn JAN
    Reply: C-Reactive Protein and Heart Failure in Patients With Established Cardiovascular Disease: Evidence From UK Biobank.
    J Am Coll Cardiol. 2023;82:e193.
    >> Share

  36. MORZE J, Rynkiewicz A
    C-Reactive Protein and Heart Failure in Patients With Established Cardiovascular Disease: Evidence From UK Biobank.
    J Am Coll Cardiol. 2023;82:e191-e192.
    >> Share

  37. LAU ES, Di Achille P, Kopparapu K, Andrews CT, et al
    Deep Learning-Enabled Assessment of Left Heart Structure and Function Predicts Cardiovascular Outcomes.
    J Am Coll Cardiol. 2023;82:1936-1948.
    >> Share

  38. OUWERKERK W, Belo Pereira JP, Maasland T, Emmens JE, et al
    Multiomics Analysis Provides Novel Pathways Related to Progression of Heart Failure.
    J Am Coll Cardiol. 2023;82:1921-1931.
    >> Share

  39. COCA SG
    SGLT2i and Deterioration of Kidney Function in Heart Failure: Another Demonstration for Tolerance of "Hypercreatininemia".
    J Am Coll Cardiol. 2023;82:1864-1867.
    >> Share

  40. AGGARWAL R, Bhatt DL, Szarek M, Cannon CP, et al
    Efficacy of Sotagliflozin in Adults With Type 2 Diabetes in Relation to Baseline Hemoglobin A1c.
    J Am Coll Cardiol. 2023;82:1842-1851.
    >> Share

    October 2023
  41. REIL JC, Eitel I, Stiermaier T
    Reply: Similarities to Pacing-Induced Heart Failure.
    J Am Coll Cardiol. 2023;82:e145.
    >> Share

  42. KOMAMURA K
    Similarities to Pacing-Induced Heart Failure.
    J Am Coll Cardiol. 2023;82:e143.
    >> Share

  43. HONG KN, Eshraghian EA, Arad M, Argiro A, et al
    International Consensus on Differential Diagnosis and Management of Patients With Danon Disease: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2023;82:1628-1647.
    >> Share

  44. ARNOLD SV, Goates S, Sorajja P, Adams DH, et al
    Health Status after Transcatheter Tricuspid-Valve Repair in Patients with Severe Tricuspid Regurgitation: Results from the TRILUMINATE Pivotal Trial.
    J Am Coll Cardiol. 2023 Oct 16:S0735-1097(23)07743.
    >> Share

  45. OHSHIRO Y
    Empagliflozin in Patients With Heart Failure: Efficacy and Safety Concerns Across Kidney Risk Categories.
    J Am Coll Cardiol. 2023;82:e133.
    >> Share

  46. TEDFORD RJ, Leacche M, Lorts A, Drakos SG, et al
    Durable Mechanical Circulatory Support: JACC Scientific Statement.
    J Am Coll Cardiol. 2023;82:1464-1481.
    >> Share

  47. GREGSON J, Stone GW, Bhatt DL, Packer M, et al
    Recurrent Events in Cardiovascular Trials: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2023;82:1445-1463.
    >> Share

    September 2023
  48. VERBRUGGE FH, Martens P, Mullens W
    Reply: Acetazolamide in Acute Decompensated Heart Failure.
    J Am Coll Cardiol. 2023;82:e113.
    >> Share

  49. PAI RG
    Acetazolamide in Acute Decompensated Heart Failure.
    J Am Coll Cardiol. 2023;82:e111.
    >> Share

  50. GOEL K, Lindenfeld J, Makkar R, Naik H, et al
    Transcatheter Edge-to-Edge Repair in 5,000 Patients With Secondary Mitral Regurgitation: COAPT Post-Approval Study.
    J Am Coll Cardiol. 2023;82:1281-1297.
    >> Share

    August 2023
  51. NAYAK A, Hall SA, Uriel N, Goldstein DJ, et al
    Predictors of 5-Year Mortality in Patients Managed With a Magnetically Levitated Left Ventricular Assist Device.
    J Am Coll Cardiol. 2023;82:771-781.
    >> Share

  52. CHATUR S, Vaduganathan M, Claggett BL, Mc Causland FR, et al
    Dapagliflozin in Patients with Heart Failure and Deterioration in Estimated Glomerular Filtration Rate to <25ml/min/1.73m(2).
    J Am Coll Cardiol. 2023 Aug 23:S0735-1097(23)06532.
    >> Share

  53. CHRISPIN J, Merchant FM, Lakdawala NK, Wu KC, et al
    Risk of Arrhythmic Death in Patients With Nonischemic Cardiomyopathy: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;82:735-747.
    >> Share

  54. GREENE SJ, Bauersachs J, Brugts JJ, Ezekowitz JA, et al
    Management of Worsening Heart Failure With Reduced Ejection Fraction: JACC Focus Seminar 3/3.
    J Am Coll Cardiol. 2023;82:559-571.
    >> Share

  55. JALLOH MB, Averbuch T, Kulkarni P, Granger CB, et al
    Bridging Treatment Implementation Gaps in Patients With Heart Failure: JACC Focus Seminar 2/3.
    J Am Coll Cardiol. 2023;82:544-558.
    >> Share

  56. PATOLIA H, Khan MS, Fonarow GC, Butler J, et al
    Implementing Guideline-Directed Medical Therapy for Heart Failure: JACC Focus Seminar 1/3.
    J Am Coll Cardiol. 2023;82:529-543.
    >> Share

  57. GRAPSA J, Pinney SP
    Right Heart Dysfunction in HFpEF: More Complex and More Common Than We Thought.
    J Am Coll Cardiol. 2023;82:500-502.
    >> Share

  58. BUTLER J, Khan MS, Fonarow GC
    The Need for Global Optimization of Heart Failure Therapy: Some Differences Do Not Matter.
    J Am Coll Cardiol. 2023 Aug 2:S0735-1097(23)05963.
    >> Share

  59. KONDO T, Wang X, Yang M, Jhund PS, et al
    Efficacy of Dapagliflozin According to Geographic Location of Patients With Heart Failure.
    J Am Coll Cardiol. 2023 Aug 2:S0735-1097(23)05964.
    >> Share

  60. SROUBEK J, Vajapey R, Sipko JJ, Soltesz EG, et al
    First-in-Human Experience With Impella 5.0/5.5 for High-Risk Patients With Advanced Heart Failure Undergoing VT Ablation.
    J Am Coll Cardiol. 2023;82:469-471.
    >> Share

  61. DEVORE AD, Allen LA
    A Global Challenge and a Global Opportunity for the Heart Failure Community.
    J Am Coll Cardiol. 2023;82:445-447.
    >> Share

  62. FOROUTAN F, Rayner DG, Ross HJ, Ehler T, et al
    Global Comparison of Readmission Rates for Patients With Heart Failure.
    J Am Coll Cardiol. 2023;82:430-444.
    >> Share

  63. JIALAL I, Ebong IA
    The Evolving Role of C-Reactive Protein in Heart Failure: Implications for Patients With Cardiovascular Disease.
    J Am Coll Cardiol. 2023;82:427-429.
    >> Share

  64. BURGER PM, Koudstaal S, Mosterd A, Fiolet ATL, et al
    C-Reactive Protein and Risk of Incident Heart Failure in Patients With Cardiovascular Disease.
    J Am Coll Cardiol. 2023;82:414-426.
    >> Share

  65. SAUER AJ, Hsia J
    Initiating Mineralocorticoid Antagonists for Longstanding Heart Failure With Reduced Ejection Fraction: Better Late Than Never?
    J Am Coll Cardiol. 2023 Aug 1:S0735-1097(23)06074.
    >> Share

  66. MATSUMOTO S, Kondo T, Jhund PS, Campbell RT, et al
    Underutilization of Mineralocorticoid Antagonists in Patients With Heart Failure With Reduced Ejection Fraction.
    J Am Coll Cardiol. 2023 Aug 1:S0735-1097(23)06073.
    >> Share

    July 2023
  67. VIJAYARAMAN P, Sharma PS, Cano O, Ponnusamy SS, et al
    Comparison of Left Bundle Branch Area Pacing and Biventricular Pacing in Candidates for Resynchronization Therapy.
    J Am Coll Cardiol. 2023;82:228-241.
    >> Share

  68. DOCHERTY KF, McDowell K, Welsh P, Osmanska J, et al
    Association of Carbohydrate Antigen 125 on the Response to Dapagliflozin in Patients With Heart Failure.
    J Am Coll Cardiol. 2023;82:142-157.
    >> Share

  69. ANKER MS, von Haehling S, Landmesser U
    Understanding Who Responds to M-TEER in Heart Failure With SMR: Malnutrition Does Not Preclude Benefit.
    J Am Coll Cardiol. 2023;82:139-141.
    >> Share

  70. BAYES-GENIS A, de la Espriella R, Nunez J
    CA125 for Fluid Overload Monitoring: A New Life for an Old Tool.
    J Am Coll Cardiol. 2023;82:158-160.
    >> Share

  71. GRINSTEIN J, Belkin MN, Kalantari S, Bourque K, et al
    Adverse Hemodynamic Consequences of Continuous Left Ventricular Mechanical Support: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;82:70-81.
    >> Share

    June 2023
  72. WIVIOTT SD, Berg DD
    SGLT2 Inhibitors Reduce Heart Failure Hospitalization and Cardiovascular Death: Clarity and Consistency.
    J Am Coll Cardiol. 2023;81:2388-2390.
    >> Share

  73. USMAN MS, Siddiqi TJ, Anker SD, Bakris GL, et al
    Effect of SGLT2 Inhibitors on Cardiovascular Outcomes Across Various Patient Populations.
    J Am Coll Cardiol. 2023;81:2377-2387.
    >> Share

  74. GODOY LC, Farkouh ME, Austin PC, Shah BR, et al
    Association of Beta-Blocker Therapy With Cardiovascular Outcomes in Patients With Stable Ischemic Heart Disease.
    J Am Coll Cardiol. 2023;81:2299-2311.
    >> Share

  75. STEVENSON LW, Ross HJ, Rathman LD, Boehmer JP, et al
    Remote Monitoring for Heart Failure Management at Home.
    J Am Coll Cardiol. 2023;81:2272-2291.
    >> Share

  76. GOLDBERG LR
    Disrupting the Definition of Heart Failure: A Rose by Any Other Name.
    J Am Coll Cardiol. 2023;81:2243-2245.
    >> Share

  77. MOHEBI R, Wang D, Lau ES, Parekh JK, et al
    Effect of 2022 ACC/AHA/HFSA Criteria on Stages of Heart Failure in a Pooled Community Cohort.
    J Am Coll Cardiol. 2023;81:2231-2242.
    >> Share

  78. LEWIS MJ, Reardon LC, Aboulhosn J, Haeffele C, et al
    Morbidity and Mortality in Adult Fontan Patients After Heart or Combined Heart-Liver Transplantation.
    J Am Coll Cardiol. 2023;81:2161-2171.
    >> Share

  79. FONAROW GC, Greene SJ
    Rapid and Intensive Guideline-Directed Medical Therapy for Heart Failure: Strong Impact Across Ejection Fraction Spectrum.
    J Am Coll Cardiol. 2023;81:2145-2148.
    >> Share

  80. PAGNESI M, Metra M, Cohen-Solal A, Edwards C, et al
    Uptitrating Treatment After Heart Failure Hospitalization Across the Spectrum of Left Ventricular Ejection Fraction.
    J Am Coll Cardiol. 2023;81:2131-2144.
    >> Share

    May 2023
  81. KAZI DS, DeJong C, Chen R, Wadhera RK, et al
    The Inflation Reduction Act and Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Disease.
    J Am Coll Cardiol. 2023;81:2103-2111.
    >> Share

  82. SCOTTI A, Coisne A, Granada JF, Driggin E, et al
    Impact of Malnutrition in Patients With Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial.
    J Am Coll Cardiol. 2023 May 27:S0735-1097(23)05584.
    >> Share

  83. SUKUMAR S, Wasfy JH, Januzzi JL, Peppercorn J, et al
    Financial Toxicity of Medical Management of Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;81:2043-2055.
    >> Share

  84. VERBRUGGE FH, Martens P, Dauw J, Nijst P, et al
    Natriuretic Response to Acetazolamide in Patients With Acute Heart Failure and Volume Overload.
    J Am Coll Cardiol. 2023;81:2013-2024.
    >> Share

  85. JOYCE E
    Natriuretic Response as a Biomarker of Decongestion in ADHF: Beyond Going With the Flow.
    J Am Coll Cardiol. 2023;81:2025-2027.
    >> Share

  86. KRISTENSEN SL, Jensen J, Schou M
    SGLT2 Inhibitors in Patients With Heart Failure and Chronic Kidney Disease: Jigsaw Falling Into Place.
    J Am Coll Cardiol. 2023;81:1915-1917.
    >> Share

  87. BUTLER J, Packer M, Siddiqi TJ, Bohm M, et al
    Efficacy of Empagliflozin in Patients With Heart Failure Across Kidney Risk Categories.
    J Am Coll Cardiol. 2023;81:1902-1914.
    >> Share

  88. INCIARDI RM, Abanda M, Shah A, Cikes M, et al
    Right Ventricular Function and Coupling to Pulmonary Circulation in Heart Failure with Preserved Ejection Fraction: The PARAGON-HF Trial.
    J Am Coll Cardiol. 2023 May 15:S0735-1097(23)05587.
    >> Share

  89. MENTZ RJ, Ward JH, Hernandez AF, Lepage S, et al
    Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure.
    J Am Coll Cardiol. 2023 May 11:S0735-1097(23)05429.
    >> Share

  90. KITTLESON MM, Panjrath GS, Amancherla K, Davis LL, et al
    2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee.
    J Am Coll Cardiol. 2023;81:1835-1878.
    >> Share

  91. BORLAUG BA, Sharma K, Shah SJ, Ho JE, et al
    Heart Failure With Preserved Ejection Fraction: JACC Scientific Statement.
    J Am Coll Cardiol. 2023;81:1810-1834.
    >> Share

  92. KODALI SK, Hahn RT, Davidson CJ, Narang A, et al
    1-Year Outcomes of Transcatheter Tricuspid Valve Repair.
    J Am Coll Cardiol. 2023;81:1766-1776.
    >> Share

  93. VENTURA HO, Lavie CJ, Mehra MR
    Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction: You Win Some, You Lose Some.
    J Am Coll Cardiol. 2023 May 3:S0735-1097(23)05526.
    >> Share

  94. MAMIC P, Snyder M, Tang WHW
    Gut Microbiome-Based Management of Patients With Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;81:1729-1739.
    >> Share

  95. FONAROW GC, Van Spall HGC, Januzzi JL Jr
    Team-Based Virtual Nudges to Overcome Clinician Inertia in Guideline-Directed Medical Therapy for Heart Failure.
    J Am Coll Cardiol. 2023;81:1694-1696.
    >> Share

    April 2023
  96. MIRANDA WR, Jain CC, Borlaug BA, Jaffe AS, et al
    Exercise Capacity, NT-proBNP, and Exercise Hemodynamics in Adults Post-Fontan.
    J Am Coll Cardiol. 2023;81:1590-1600.
    >> Share

  97. LENA A, Wilkenshoff U, Hadzibegovic S, Porthun J, et al
    Clinical and Prognostic Relevance of Cardiac Wasting in Patients With Advanced Cancer.
    J Am Coll Cardiol. 2023;81:1569-1586.
    >> Share

  98. VERMA S, Bhatt DL, Dhingra NK, Steg PG, et al
    Time to Benefit With Sotagliflozin in Patients With Worsening Heart Failure.
    J Am Coll Cardiol. 2023;81:1546-1549.
    >> Share

  99. KHAN H, Kunutsor SK
    Nonsteroidal Anti-Inflammatory Drugs and Type 2 Diabetes: A Recipe for Heart Failure?
    J Am Coll Cardiol. 2023;81:1471-1473.
    >> Share

  100. HOLT A, Strange JE, Nouhravesh N, Nielsen SK, et al
    Heart Failure Following Anti-Inflammatory Medications in Patients With Type 2 Diabetes Mellitus.
    J Am Coll Cardiol. 2023;81:1459-1470.
    >> Share

  101. COCA SG
    Learning to Embrace the Decline in eGFR After Initiation of Therapies for Heart Failure.
    J Am Coll Cardiol. 2023;81:1456-1458.
    >> Share

  102. AHMAD T, Desai NR, Clark KAA
    The EHR Has Exposed an Urgent Moral Imperative to Improve Heart Failure Care.
    J Am Coll Cardiol. 2023;81:1317-1319.
    >> Share

  103. YUN M, Bai Y, Nie B, Zhang X, et al
    Reply: Specific Brain-Heart Axis-Related Pathomechanism in Heart Failure Are Revealed Through Analysis of Cardiovascular Dynamics.
    J Am Coll Cardiol. 2023;81:e111.
    >> Share

  104. VALENZA G
    Specific Brain-Heart Axis-Related Pathomechanism in Heart Failure Are Revealed Through Analysis of Cardiovascular Dynamics.
    J Am Coll Cardiol. 2023;81:e109.
    >> Share

  105. CARNICELLI AP, Agarwal R, Tedford RJ, Ramaiah V, et al
    Critical Care Enrichment During Advanced Heart Failure Training.
    J Am Coll Cardiol. 2023;81:1296-1299.
    >> Share

  106. SORAJJA P, Cavalcante JL, Rodes-Cabau J
    Upstream Relief of Heart Failure Via Aortic Valve Replacement.
    J Am Coll Cardiol. 2023;81:1245-1247.
    >> Share

  107. KHAN KR, Khan OA, Chen C, Liu Y, et al
    Impact of Moderate Aortic Stenosis in Patients With Heart Failure With Reduced Ejection Fraction.
    J Am Coll Cardiol. 2023;81:1235-1244.
    >> Share

    March 2023
  108. DOMANSKI MJ, Wu CO, Tian X, Hasan AA, et al
    Association of Incident Cardiovascular Disease With Time Course and Cumulative Exposure to Multiple Risk Factors.
    J Am Coll Cardiol. 2023;81:1151-1161.
    >> Share

  109. LYNCH A, Tatangelo M, Ahuja S, Steve Fan CP, et al
    Risk of Sudden Death in Patients With RASopathy Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2023;81:1035-1045.
    >> Share

  110. DISMORR M, Glaser N, Franco-Cereceda A, Sartipy U, et al
    Effect of Prosthesis-Patient Mismatch on Long-Term Clinical Outcomes After Bioprosthetic Aortic Valve Replacement.
    J Am Coll Cardiol. 2023;81:964-975.
    >> Share

  111. VADUGANATHAN M, Claggett BL, Jhund P, Miao ZM, et al
    Dapagliflozin and All-Cause Hospitalizations in Patients With Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2023;81:1004-1006.
    >> Share

  112. SACHDEV V, Sharma K, Keteyian SJ, Alcain CF, et al
    Supervised Exercise Training for Chronic Heart Failure With Preserved Ejection Fraction: A Scientific Statement From the American Heart Association and American College of Cardiology.
    J Am Coll Cardiol. 2023 Mar 14:S0735-1097(23)00368.
    >> Share

  113. LAZARO I, Lupon J, Cediel G, Sala-Vila A, et al
    Reply: Circulating Vegetable Omega-3 and Prognosis in Patients With Heart Failure: More Data Are Needed.
    J Am Coll Cardiol. 2023;81:e69.
    >> Share

  114. WU J, Liang J, Huang Y
    Circulating Vegetable Omega-3 and Prognosis in Patients With Heart Failure: More Data Are Needed.
    J Am Coll Cardiol. 2023;81:e67.
    >> Share

  115. MENASCHE P
    Mesenchymal Stromal Cell Therapy for Heart Failure: Never Stop DREAMing.
    J Am Coll Cardiol. 2023;81:864-866.
    >> Share

  116. PERIN EC, Borow KM, Henry TD, Mendelsohn FO, et al
    Randomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy in Patients With Heart Failure.
    J Am Coll Cardiol. 2023;81:849-863.
    >> Share

    February 2023
  117. WECKBACH LT, Stolz L, Chatfield AG, Fam NP, et al
    Right Ventricular Reverse Remodeling After Transcatheter Tricuspid Valve Replacement in Patients With Heart Failure.
    J Am Coll Cardiol. 2023;81:708-710.
    >> Share

  118. BHATT AS, Varshney AS, Moscone A, Claggett BL, et al
    Virtual Care Team-Guided Therapeutic Optimization During Hospitalization in Patients with Heart Failure: The IMPLEMENT-HF Study.
    J Am Coll Cardiol. 2023 Feb 21:S0735-1097(23)04471.
    >> Share

  119. CHATUR S, Claggett BL, McCausland FR, Rouleau J, et al
    Variation in Renal Function Following Transition to Sacubitril/Valsartan in Patients with Heart Failure.
    J Am Coll Cardiol. 2023 Feb 9:S0735-1097(23)00335.
    >> Share

  120. MUKHOPADHYAY A, Reynolds HR, Phillips LM, Nagler AR, et al
    Cluster-Randomized Trial Comparing Ambulatory Decision Support Tools to Improve Heart Failure Care.
    J Am Coll Cardiol. 2023 Feb 9:S0735-1097(23)00329.
    >> Share

  121. WEINTRAUB WS
    Improving the Quality of Life for Patients With Heart Failure and Preserved Ejection Fraction.
    J Am Coll Cardiol. 2023;81:474-476.
    >> Share

  122. KOSIBOROD MN, Bhatt AS, Claggett BL, Vaduganathan M, et al
    Effect of Dapagliflozin on Health Status in Patients With Preserved or Mildly Reduced Ejection Fraction.
    J Am Coll Cardiol. 2023;81:460-473.
    >> Share

    January 2023
  123. GREENE SJ, Bauersachs J, Brugts JJ, Ezekowitz JA, et al
    Worsening Heart Failure: Nomenclature, Epidemiology, and Future Directions: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;81:413-424.
    >> Share

  124. PAGE RL 2ND
    The Real-World Price of Switching to an ARNI: A Case for De Novo Sacubitril/Valsartan Initiation.
    J Am Coll Cardiol. 2023;81:332-335.
    >> Share

  125. KHAN MS, Shahid I, Anker SD, Fonarow GC, et al
    Albuminuria and Heart Failure: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2023;81:270-282.
    >> Share

  126. MENTIAS A, Smedira NG, Krishnaswamy A, Reed GW, et al
    Survival After Septal Reduction in Patients >65 Years Old With Obstructive Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2023;81:105-115.
    >> Share

  127. MARON MS, Masri A, Choudhury L, Olivotto I, et al
    Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2023;81:34-45.
    >> Share

    December 2022
  128. LAI FTT, Chan EWW, Huang L, Cheung CL, et al
    Prognosis of Myocarditis Developing After mRNA COVID-19 Vaccination Compared With Viral Myocarditis.
    J Am Coll Cardiol. 2022;80:2255-2265.
    >> Share

  129. MOORE JP, Marelli A, Burchill LJ, Chubb H, et al
    Management of Heart Failure With Arrhythmia in Adults With Congenital Heart Disease: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;80:2224-2238.
    >> Share

  130. MA H, Wang X, Li X, Heianza Y, et al
    Adding Salt to Foods and Risk of Cardiovascular Disease.
    J Am Coll Cardiol. 2022;80:2157-2167.
    >> Share

    November 2022
  131. CHANG YK, McClung JA, Allen LA, Philip J, et al
    Reply: Early Integration of Specialist Palliative Care in Advanced Heart Failure: A Multipronged Approach.
    J Am Coll Cardiol. 2022;80:e205-e206.
    >> Share

  132. AREVALO LORIDO JC, Salamanca Bautista P, Formiga F, Mendez Bailon M, et al
    Tackling Palliative Care in Advanced Heart Failure.
    J Am Coll Cardiol. 2022;80:e203-e204.
    >> Share

  133. RICKETTI DA, Krickus CL
    Strain on Palliative Care Services May Limit Resources for Advanced Heart Failure Patients.
    J Am Coll Cardiol. 2022;80:e201.
    >> Share

  134. PAHUJA M, Johnson A, Kabir R, Bhogal S, et al
    Randomized Trials of Percutaneous Microaxial Flow Pump Devices: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;80:2028-2049.
    >> Share

  135. SCHINDLER TH, Valenta I, Dilsizian V
    Disturbances in Brain-Heart Neuronal-Metabolic Axis Are Associated With Major Arrhythmic Events in Heart Failure.
    J Am Coll Cardiol. 2022;80:1897-1899.
    >> Share

  136. BAI Y, Yun M, Nie B, Shan L, et al
    Neurometabolism and Ventricular Dyssynchrony in Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2022;80:1884-1896.
    >> Share

  137. GIUSTINO G, Camaj A, Kapadia SR, Kar S, et al
    Hospitalizations and Mortality in Patients With Secondary Mitral Regurgitation and Heart Failure: The COAPT Trial.
    J Am Coll Cardiol. 2022;80:1857-1868.
    >> Share

  138. NASSIF ME, Januzzi JL Jr
    Implementing Sodium-Glucose Cotransporter-2 Inhibitor Therapy for Heart Failure: What Is the Message to DELIVER?
    J Am Coll Cardiol. 2022;80:1785-1787.
    >> Share

  139. VADUGANATHAN M, Claggett BL, Jhund P, de Boer RA, et al
    Estimated Long-Term Benefit of Dapagliflozin in Patients With Heart Failure.
    J Am Coll Cardiol. 2022;80:1775-1784.
    >> Share

  140. AL-MOHAMMAD A
    Circulating Plant-Based Omega-3 in Heart Failure: A Prognostic Marker or a Therapeutic Target?
    J Am Coll Cardiol. 2022;80:1759-1761.
    >> Share

  141. LAZARO I, Lupon J, Cediel G, Codina P, et al
    Relationship of Circulating Vegetable Omega-3 to Prognosis in Patients With Heart Failure.
    J Am Coll Cardiol. 2022;80:1751-1758.
    >> Share

  142. ZANNAD F
    Heart Failure and Kidney Disease in Type 2 Diabetes: 2 Sides of the Same Coin.
    J Am Coll Cardiol. 2022;80:1732-1734.
    >> Share

  143. SARRAJU A, Bakris G, Cannon CP, Cherney D, et al
    Cardiovascular Effects of Canagliflozin in Relation to Renal Function and Albuminuria.
    J Am Coll Cardiol. 2022;80:1721-1731.
    >> Share

    October 2022
  144. SALAH HM, Goldberg LR, Molinger J, Felker GM, et al
    Diaphragmatic Function in Cardiovascular Disease: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2022;80:1647-1659.
    >> Share

  145. MOHEBI R, Liu Y, Pina IL, Prescott MF, et al
    Dose-Response to Sacubitril/Valsartan in Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2022;80:1529-1541.
    >> Share

  146. WALSH MN
    Guideline-Directed Medical Therapy: Even a Little Is Better Than None.
    J Am Coll Cardiol. 2022;80:1542-1544.
    >> Share

  147. ASCHER SB, de Lemos JA, Lee M, Wu E, et al
    Intensive Blood Pressure Lowering in Patients With Malignant Left Ventricular Hypertrophy.
    J Am Coll Cardiol. 2022;80:1516-1525.
    >> Share

  148. JANUSZEWICZ A, Mulatero P, Dobrowolski P, Monticone S, et al
    Cardiac Phenotypes in Secondary Hypertension: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;80:1480-1497.
    >> Share

  149. SAVVATIS K, Vissing CR, Klouvi L, Florian A, et al
    Cardiac Outcomes in Adults With Mitochondrial Diseases.
    J Am Coll Cardiol. 2022;80:1421-1430.
    >> Share

  150. DE FRUTOS F, Ochoa JP, Navarro-Penalver M, Baas A, et al
    Natural History of MYH7-Related Dilated Cardiomyopathy.
    J Am Coll Cardiol. 2022;80:1447-1461.
    >> Share

  151. D'ALESSANDRO DA, Wolfe SB, Osho AA, Drezek K, et al
    Hemodynamic and Clinical Performance of Hearts Donated After Circulatory Death.
    J Am Coll Cardiol. 2022;80:1314-1326.
    >> Share

    September 2022
  152. VIJAYARAMAN P, Batul SA
    Left Bundle Branch Pacing for Cardiac Resynchronization: Are We Ready for a Leap of Faith?
    J Am Coll Cardiol. 2022;80:1217-1219.
    >> Share

  153. WANG Y, Zhu H, Hou X, Wang Z, et al
    Randomized Trial of Left Bundle Branch vs Biventricular Pacing for Cardiac Resynchronization Therapy.
    J Am Coll Cardiol. 2022;80:1205-1216.
    >> Share

  154. KARAMLOU T, Devlin PJ, Hammoud MS
    Late Systemic Right Ventricle Failure: Moving Toward a Real-Time Prediction Tool.
    J Am Coll Cardiol. 2022;80:964-966.
    >> Share

  155. BROBERG CS, van Dissel A, Minnier J, Aboulhosn J, et al
    Long-Term Outcomes After Atrial Switch Operation for Transposition of the Great Arteries.
    J Am Coll Cardiol. 2022;80:951-963.
    >> Share

    August 2022
  156. IDRISS SF, Weiland MD
    Ventricular Pacing in Single Ventricle Circulation: Making the Best of a Difficult Situation.
    J Am Coll Cardiol. 2022;80:915-917.
    >> Share

  157. BUTT JH, Dewan P, Jhund PS, Anand IS, et al
    Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction.
    J Am Coll Cardiol. 2022 Aug 26. pii: S0735-1097(22)05596.
    >> Share

  158. AHMAD T, Desai NR, Velazquez EJ
    SGLT2 Inhibitors Should Be Considered for All Patients With Heart Failure.
    J Am Coll Cardiol. 2022 Aug 26. pii: S0735-1097(22)05770.
    >> Share

  159. CUNNINGHAM JW, Vaduganathan M, Claggett BL, Kulac IJ, et al
    Dapagliflozin in Patients Recently Hospitalized With Heart Failure and Mildly Reduced or Preserved Ejection Fraction.
    J Am Coll Cardiol. 2022 Aug 26. pii: S0735-1097(22)05673.
    >> Share

  160. LA GERCHE A, Howden EJ, Haykowsky MJ, Lewis GD, et al
    Heart Failure With Preserved Ejection Fraction as an Exercise Deficiency Syndrome: JACC Focus Seminar 2/4.
    J Am Coll Cardiol. 2022 Aug 24. pii: S0735-1097(22)05603.
    >> Share

  161. LAU ES, Ho JE
    Reply: Previous Pregnancies and Heart Failure Prognosis.
    J Am Coll Cardiol. 2022;80:e61-e62.
    >> Share

  162. MARTINEZ-SELLES M
    Previous Pregnancies and Heart Failure Prognosis.
    J Am Coll Cardiol. 2022;80:e59.
    >> Share

  163. CORBALAN R, Acevedo M
    Glifozins and Atrial Fibrillation.
    J Am Coll Cardiol. 2022 Aug 23. pii: S0735-1097(22)06612.
    >> Share

  164. BUTT JH, Kondo T, Jhund PS, Comin-Colet J, et al
    Dapagliflozin, atrial fibrillation, and heart failure with mildly reduced or preserved ejection fraction in DELIVER.
    J Am Coll Cardiol. 2022 Aug 13. pii: S0735-1097(22)06529.
    >> Share

  165. HECKMAN GA, Rockwood K
    Frailty, Risk, and Heart Failure Care: Commission or Omission?
    J Am Coll Cardiol. 2022 Aug 12. pii: S0735-1097(22)05597.
    >> Share

  166. BOCCHI EA, Lima IGCV
    The Challenge of Reducing Complexity of Heart Failure Treatment Without Losing Efficacy: Quo Vadis?
    J Am Coll Cardiol. 2022;80:595-597.
    >> Share

  167. YE F, Wang X, Wu S, Ma S, et al
    Sustained-Release Ivabradine Hemisulfate in Patients With Systolic Heart Failure.
    J Am Coll Cardiol. 2022;80:584-594.
    >> Share

  168. MOHEBI R, Chen C, Ibrahim NE, McCarthy CP, et al
    Cardiovascular Disease Projections in the United States Based on the 2020 Census Estimates.
    J Am Coll Cardiol. 2022;80:565-578.
    >> Share

  169. WILEY BM, Borlaug BA, Kane GC
    Lung Ultrasound in Heart Failure: Envisioning Handheld Ultrasound to Empower Nurses and Transform Health Care.
    J Am Coll Cardiol. 2022;80:524-526.
    >> Share

  170. ZISIS G, Yang Y, Huynh Q, Whitmore K, et al
    Nurse-Provided Lung and Inferior Vena Cava Assessment in Patients With Heart Failure.
    J Am Coll Cardiol. 2022;80:513-523.
    >> Share

    July 2022
  171. BADRAN S, Lee S
    Even in Heart Failure, Integrating Palliative Care and Aggressive Medical Therapy Is a Thing.
    J Am Coll Cardiol. 2022;80:345-347.
    >> Share

  172. CHANG YK, Allen LA, McClung JA, Denvir MA, et al
    Criteria for Referral of Patients With Advanced Heart Failure for Specialized Palliative Care.
    J Am Coll Cardiol. 2022;80:332-344.
    >> Share

  173. KOCHAR A, Smilowitz NR, Hochman JS
    Dynamic Cardiogenic Shock Classification: 2 Steps Forward, 1 Step Back.
    J Am Coll Cardiol. 2022;80:199-201.
    >> Share

  174. KAPUR NK, Kanwar M, Sinha SS, Thayer KL, et al
    Criteria for Defining Stages of Cardiogenic Shock Severity.
    J Am Coll Cardiol. 2022;80:185-198.
    >> Share

  175. JANUZZI JL JR, Butler J
    The Importance of Worsening Heart Failure: Hiding in Plain Sight.
    J Am Coll Cardiol. 2022;80:123-125.
    >> Share

  176. AMBROSY AP, Parikh RV, Sung SH, Tan TC, et al
    Analysis of Worsening Heart Failure Events in an Integrated Health Care System.
    J Am Coll Cardiol. 2022;80:111-122.
    >> Share

  177. SAUER AJ
    Empagliflozin and Elderly Patients With Preserved Ejection Fraction Heart Failure: Is Age Just a Number?
    J Am Coll Cardiol. 2022;80:19-21.
    >> Share

  178. BOHM M, Butler J, Filippatos G, Ferreira JP, et al
    Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of Age.
    J Am Coll Cardiol. 2022;80:1-18.
    >> Share

  179. FLORIDO R, Daya NR, Ndumele CE, Koton S, et al
    Cardiovascular Disease Risk Among Cancer Survivors: The Atherosclerosis Risk In Communities (ARIC) Study.
    J Am Coll Cardiol. 2022;80:22-32.
    >> Share

    June 2022
  180. WASFY JH, O'Kelly AC
    Value-Based Prices Could Establish Common Ground on Heart Failure Drug Pricing and Coverage.
    J Am Coll Cardiol. 2022;79:2526-2528.
    >> Share

  181. FARIDI KF, Dayoub EJ, Ross JS, Dhruva SS, et al
    Medicare Coverage and Out-of-Pocket Costs of Quadruple Drug Therapy for Heart Failure.
    J Am Coll Cardiol. 2022;79:2516-2525.
    >> Share

  182. PRASADA S, Desai MY, Saad M, Smilowitz NR, et al
    Preoperative Atrial Fibrillation and Cardiovascular Outcomes After Noncardiac Surgery.
    J Am Coll Cardiol. 2022;79:2471-2485.
    >> Share

  183. BIONDI-ZOCCAI G, Peruzzi M, Frati G
    Is Smoking Cessation the Best Intervention Ever to Prevent Heart Failure?
    J Am Coll Cardiol. 2022;79:2306-2309.
    >> Share

  184. DING N, Shah AM, Blaha MJ, Chang PP, et al
    Cigarette Smoking, Cessation, and Risk of Heart Failure With Preserved and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2022;79:2298-2305.
    >> Share

  185. VERMA S, Pandey A, Bhatt DL
    Forecasting Heart Failure Risk in Diabetes.
    J Am Coll Cardiol. 2022;79:2294-2297.
    >> Share

  186. ECHOUFFO-TCHEUGUI JB, Ndumele CE, Zhang S, Florido R, et al
    Diabetes and Progression of Heart Failure: The Atherosclerosis Risk In Communities (ARIC) Study.
    J Am Coll Cardiol. 2022;79:2285-2293.
    >> Share

  187. AJOOLABADY A, Nattel S, Lip GYH, Ren J, et al
    Inflammasome Signaling in Atrial Fibrillation: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;79:2349-2366.
    >> Share

    May 2022
  188. SCHOCKEN DD
    Registry Evidence for Modulation of the Acute Ischemic Heart Disease Pathway: Statins Prevent Heart Failure?
    J Am Coll Cardiol. 2022;79:2034-2036.
    >> Share

  189. BUGIARDINI R, Yoon J, Mendieta G, Kedev S, et al
    Reduced Heart Failure and Mortality in Patients Receiving Statin Therapy Before Initial Acute Coronary Syndrome.
    J Am Coll Cardiol. 2022;79:2021-2033.
    >> Share

  190. UDELL JA, Jones WS, Petrie MC, Harrington J, et al
    Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2022;79:2058-2068.
    >> Share

  191. NORRISH G, Cleary A, Field E, Cervi E, et al
    Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2022;79:1986-1997.
    >> Share

  192. DALY KP, Zuckerman WA
    The Burden of Pediatric Heart Failure That Lies Just Under the Surface.
    J Am Coll Cardiol. 2022;79:1929-1931.
    >> Share

  193. AMDANI S, Marino BS, Rossano J, Lopez R, et al
    Burden of Pediatric Heart Failure in the United States.
    J Am Coll Cardiol. 2022;79:1917-1928.
    >> Share

  194. FUDIM M, Kaye DM, Borlaug BA, Shah SJ, et al
    Venous Tone and Stressed Blood Volume in Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2022;79:1858-1869.
    >> Share

    April 2022
  195. DRIGGIN E, Cohen LP, Gallagher D, Karmally W, et al
    Nutrition Assessment and Dietary Interventions in Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2022;79:1623-1635.
    >> Share

  196. DEFILIPPIS EM
    Infertility: A Fertile Ground for Heart Failure?
    J Am Coll Cardiol. 2022;79:1604-1605.
    >> Share

  197. LAU ES, Wang D, Roberts M, Taylor CN, et al
    Infertility and Risk of Heart Failure in the Women's Health Initiative.
    J Am Coll Cardiol. 2022;79:1594-1603.
    >> Share

  198. NEGISHI K, Pathan F
    Novel Left Atrial Markers for Risk Stratification of Heart Failure: Ready for Prime Time?
    J Am Coll Cardiol. 2022;79:1562-1564.
    >> Share

  199. INCIARDI RM, Claggett B, Minamisawa M, Shin SH, et al
    Association of Left Atrial Structure and Function With Heart Failure in Older Adults.
    J Am Coll Cardiol. 2022;79:1549-1561.
    >> Share

  200. KHAN SS, Beach LB, Yancy CW
    Sex-Based Differences in Heart Failure: JACC Focus Seminar 7/7.
    J Am Coll Cardiol. 2022;79:1530-1541.
    >> Share

  201. ARENAL A, Avila P, Jimenez-Candil J, Tercedor L, et al
    Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia.
    J Am Coll Cardiol. 2022;79:1441-1453.
    >> Share

  202. MENTIAS A, Aminian A, Youssef D, Pandey A, et al
    Long-Term Cardiovascular Outcomes After Bariatric Surgery in the Medicare Population.
    J Am Coll Cardiol. 2022;79:1429-1437.
    >> Share

  203. LINDLEY KJ, Williams D, Davila-Roman VG
    Reply: When Preclinical Data Meet Epidemiology: Preeclampsia and Future HFpEF.
    J Am Coll Cardiol. 2022;79:e243.
    >> Share

  204. SCIATTI E, Orabona R
    When Preclinical Data Meet Epidemiology: Preeclampsia and Future HFpEF.
    J Am Coll Cardiol. 2022;79:e241.
    >> Share

  205. KRIEGER EV, Kim YY
    Lumping vs Splitting in Adult Congenital Heart Disease Research.
    J Am Coll Cardiol. 2022;79:1366-1368.
    >> Share

    March 2022
  206. FERREIRA JP, Butler J, Zannad F, Filippatos G, et al
    Mineralocorticoid Receptor Antagonists and Empagliflozin in Patients With Heart Failure and Preserved Ejection Fraction.
    J Am Coll Cardiol. 2022;79:1129-1137.
    >> Share

  207. VAN SPALL HGC, Fonarow GC, Mamas MA
    Under-utilization of Guideline-Directed Medical Therapy in Heart Failure: Can Digital Health Technologies PROMPT Change?
    J Am Coll Cardiol. 2022 Mar 24. pii: S0735-1097(22)04564.
    >> Share

  208. HEIDENREICH PA, Bozkurt B, Aguilar D, Allen LA, et al
    2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    J Am Coll Cardiol. 2022 Mar 24. pii: S0735-1097(21)08394.
    >> Share

  209. HEIDENREICH PA, Bozkurt B, Aguilar D, Allen LA, et al
    2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    J Am Coll Cardiol. 2022 Mar 24. pii: S0735-1097(21)08395.
    >> Share

  210. VARSHNEY AS, DeFilippis EM, Cowger JA, Netuka I, et al
    Trends and Outcomes of Left Ventricular Assist Device Therapy: JACC Focus Seminar.
    J Am Coll Cardiol. 2022;79:1092-1107.
    >> Share

  211. GHAZI L, Yamamoto Y, Riello RJ, Coronel-Moreno C, et al
    Electronic Alerts to Improve Heart Failure Therapy in Outpatient Practice: A Cluster Randomized Trial.
    J Am Coll Cardiol. 2022 Mar 19. pii: S0735-1097(22)04489.
    >> Share

  212. PALAU P, Seller J, Dominguez E, Bayes-Genis A, et al
    Reply: Beta-Blocker Withdrawal and Chronotropic Incompetence in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2022;79:e197-e198.
    >> Share

  213. FAUCHIER L, Bodin A, Bisson A
    Beta-Blocker Withdrawal and Chronotropic Incompetence in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2022;79:e195.
    >> Share

  214. JANUZZI JL JR, Ohman EM
    Underdiagnosis of Ischemic Heart Disease in New-Onset Heart Failure: A Call to Action.
    J Am Coll Cardiol. 2022;79:861-863.
    >> Share

  215. ZHENG J, Heidenreich PA, Kohsaka S, Fearon WF, et al
    Variability in Coronary Artery Disease Testing for Patients With New-Onset Heart Failure.
    J Am Coll Cardiol. 2022;79:849-860.
    >> Share

  216. TOPKARA VK, Sayer GT, Clerkin KJ, Wever-Pinzon O, et al
    Recovery With Temporary Mechanical Circulatory Support While Waitlisted for Heart Transplantation.
    J Am Coll Cardiol. 2022;79:900-913.
    >> Share

  217. JEFFERIES JL, Saffitz JE
    Autophagy and Reverse Remodeling: A New Biomarker in Heart Failure?
    J Am Coll Cardiol. 2022;79:802-804.
    >> Share

  218. KANAMORI H, Yoshida A, Naruse G, Endo S, et al
    Impact of Autophagy on Prognosis of Patients With Dilated Cardiomyopathy.
    J Am Coll Cardiol. 2022;79:789-801.
    >> Share

    February 2022
  219. FIUZAT M, Hamo CE, Butler J, Abraham WT, et al
    Optimal Background Pharmacological Therapy for Heart Failure Patients in Clinical Trials: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2022;79:504-510.
    >> Share

  220. VADUGANATHAN M, Sattar N, Xu J, Butler J, et al
    Stress Cardiac Biomarkers, Cardiovascular and Renal Outcomes, and Response to Canagliflozin.
    J Am Coll Cardiol. 2022;79:432-444.
    >> Share

  221. FONTES JD, Massera D
    The Path to Better Understanding Heart Failure Epidemiology.
    J Am Coll Cardiol. 2022;79:369-371.
    >> Share

  222. CHANDRA A, Skali H, Claggett B, Solomon SD, et al
    Race- and Gender-Based Differences in Cardiac Structure and Function and Risk of Heart Failure.
    J Am Coll Cardiol. 2022;79:355-368.
    >> Share

  223. MASINI G, Graham FJ, Pellicori P, Cleland JGF, et al
    Criteria for Iron Deficiency in Patients With Heart Failure.
    J Am Coll Cardiol. 2022;79:341-351.
    >> Share

  224. COSTANZO MR, Januzzi JL Jr
    21st Century CE: The New Iron Age?
    J Am Coll Cardiol. 2022;79:352-354.
    >> Share

    January 2022
  225. LOCCOH EC, Joynt Maddox KE, Wang Y, Kazi DS, et al
    Rural-Urban Disparities in Outcomes of Myocardial Infarction, Heart Failure, and Stroke in the United States.
    J Am Coll Cardiol. 2022;79:267-279.
    >> Share

  226. WALSH MN
    Change in Lifetime Risk of Heart Failure: Applicable to All?
    J Am Coll Cardiol. 2022;79:264-266.
    >> Share

  227. VASAN RS, Enserro DM, Beiser AS, Xanthakis V, et al
    Lifetime Risk of Heart Failure Among Participants in the Framingham Study.
    J Am Coll Cardiol. 2022;79:250-263.
    >> Share

  228. MANTOVANI A, Byrne CD, Benfari G, Bonapace S, et al
    Risk of Heart Failure in Patients With Nonalcoholic Fatty Liver Disease: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2022;79:180-191.
    >> Share

  229. VOLGMAN AS, Nair G, Lyubarova R, Merchant FM, et al
    Management of Atrial Fibrillation in Patients 75 Years and Older: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;79:166-179.
    >> Share

  230. BERRY C, Ibanez B
    Intramyocardial Hemorrhage: The Final Frontier for Preventing Heart Failure Post-Myocardial Infarction.
    J Am Coll Cardiol. 2022;79:49-51.
    >> Share

    December 2021
  231. EMERSON D, Chikwe J, Catarino P, Kobashigawa J, et al
    Reply: Do Elderly Patients With Advanced Heart Failure Have Better Outcomes After LVAD?
    J Am Coll Cardiol. 2021;78:e323.
    >> Share

  232. RODENAS-ALESINA E, Billia F, Rao V, Ross HJ, et al
    Do Elderly Patients With Advanced Heart Failure Have Better Outcomes After LVAD?
    J Am Coll Cardiol. 2021;78:e321.
    >> Share

  233. PINA IL, Jimenez S, Lewis EF, Morris AA, et al
    Race and Ethnicity in Heart Failure: JACC Focus Seminar 8/9.
    J Am Coll Cardiol. 2021;78:2589-2598.
    >> Share

  234. RAME JE, Pagani FD, Kiernan MS, Oliveira GH, et al
    Evolution of Late Right Heart Failure With Left Ventricular Assist Devices and Association With Outcomes.
    J Am Coll Cardiol. 2021;78:2294-2308.
    >> Share

  235. HONIGBERG MC
    Understanding Heart Failure in Women With Preeclampsia: A Call for Prevention.
    J Am Coll Cardiol. 2021;78:2291-2293.
    >> Share

  236. WILLIAMS D, Stout MJ, Rosenbloom JI, Olsen MA, et al
    Preeclampsia Predicts Risk of Hospitalization for Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2021;78:2281-2290.
    >> Share

    November 2021
  237. GANDHI PU, Windish DM
    Heart Failure Biomarker Education: An Unmet Need in Cardiovascular Fellowship Training.
    J Am Coll Cardiol. 2021;78:2265-2266.
    >> Share

  238. PALAU P, Seller J, Dominguez E, Sastre C, et al
    Effect of beta-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction.
    J Am Coll Cardiol. 2021;78:2042-2056.
    >> Share

  239. GUAZZI M
    The Link Between Heart Rate, Exercise, and beta-Blocker in HFpEF: Time to Untie the Knot.
    J Am Coll Cardiol. 2021;78:2057-2059.
    >> Share

  240. ZHANG J, Bolli R, Garry DJ, Marban E, et al
    Basic and Translational Research in Cardiac Repair and Regeneration: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;78:2092-2105.
    >> Share

  241. GOTTLIEB SH
    Heart Failure With Reduced Ejection Fraction: "Guideline-Directed Medical Therapy (GDMT)" Versus "The Art of Medicine".
    J Am Coll Cardiol. 2021;78:2013-2016.
    >> Share

  242. RAO VN, Murray E, Butler J, Cooper LB, et al
    In-Hospital Initiation of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Reduced Ejection Fraction.
    J Am Coll Cardiol. 2021;78:2004-2012.
    >> Share

  243. KINDEL SJ
    Pediatric Data for Pediatric Heart Failure: Stepping Out on Our Own.
    J Am Coll Cardiol. 2021;78:1901-1903.
    >> Share

  244. PALM J, Holdenrieder S, Hoffmann G, Horer J, et al
    Predicting Major Adverse Cardiovascular Events in Children With Age-Adjusted NT-proBNP.
    J Am Coll Cardiol. 2021;78:1890-1900.
    >> Share

  245. AMBARDEKAR AV, Stratton MS, Dobrinskikh E, Hunter KS, et al
    Matrix-Degrading Enzyme Expression and Aortic Fibrosis During Continuous-Flow Left Ventricular Mechanical Support.
    J Am Coll Cardiol. 2021;78:1782-1795.
    >> Share

  246. WANNER PM, Wulff DU, Djurdjevic M, Korte W, et al
    Targeting Higher Intraoperative Blood Pressures Does Not Reduce Adverse Cardiovascular Events Following Noncardiac Surgery.
    J Am Coll Cardiol. 2021;78:1753-1764.
    >> Share

    October 2021
  247. KLEINER SHOCHAT M, Fudim M, Kapustin D, Kazatsker M, et al
    Early Impedance-Guided Intervention Improves Long-Term Outcome in Patients With Heart Failure.
    J Am Coll Cardiol. 2021;78:1751-1752.
    >> Share

  248. ESCOBAR-LOPEZ L, Ochoa JP, Mirelis JG, Espinosa MA, et al
    Association of Genetic Variants With Outcomes in Patients With Nonischemic Dilated Cardiomyopathy.
    J Am Coll Cardiol. 2021;78:1682-1699.
    >> Share

  249. ITOGA NK, Tawfik DS, Montez-Rath ME, Chang TI, et al
    Contributions of Systolic and Diastolic Blood Pressures to Cardiovascular Outcomes in the ALLHAT Study.
    J Am Coll Cardiol. 2021;78:1671-1678.
    >> Share

  250. RANGASWAMI J, Lo KB, Vaduganathan M, Mathew RO, et al
    Eligibility for SGLT2 Inhibitors in Heart Failure Without the Race Coefficient for Kidney Function Estimation.
    J Am Coll Cardiol. 2021;78:1669-1670.
    >> Share

  251. SEGAR MW, Khan MS, Patel KV, Butler J, et al
    Prevalence and Prognostic Implications of Diabetes With Cardiomyopathy in Community-Dwelling Adults.
    J Am Coll Cardiol. 2021;78:1587-1598.
    >> Share

  252. KENCHAIAH S, Budoff MJ, Ding J, Carr JJ, et al
    Reply: Prognostic Role of Pericardial Fat on the Incidence of Heart Failure.
    J Am Coll Cardiol. 2021;78:e113-e115.
    >> Share

  253. BONAPACE S, Molon G, Marinelli A, Lanzoni L, et al
    Prognostic Role of Pericardial Fat on the Incidence of Heart Failure.
    J Am Coll Cardiol. 2021;78:e111.
    >> Share

  254. LEE HH, Lee H, Cho SMJ, Kim DW, et al
    On-Treatment Blood Pressure and Cardiovascular Outcomes in Adults With Hypertension and Left Ventricular Hypertrophy.
    J Am Coll Cardiol. 2021;78:1485-1495.
    >> Share

    September 2021
  255. BOHM M, Anker SD, Butler J, Filippatos G, et al
    Empagliflozin Improves Cardiovascular and Renal Outcomes in Heart Failure Irrespective of Systolic Blood Pressure.
    J Am Coll Cardiol. 2021;78:1337-1348.
    >> Share

  256. CUNNINGHAM JW, Myhre PL
    NT-proBNP Response to Heart Failure Therapies: An Imperfect Surrogate.
    J Am Coll Cardiol. 2021;78:1333-1336.
    >> Share

  257. JANUZZI JL JR, Zannad F, Anker SD, Butler J, et al
    Prognostic Importance of NT-proBNP and Effect of Empagliflozin in the EMPEROR-Reduced Trial.
    J Am Coll Cardiol. 2021;78:1321-1332.
    >> Share

  258. PANDEY A, Shah SJ, Butler J, Kellogg DL Jr, et al
    Exercise Intolerance in Older Adults With Heart Failure With Preserved Ejection Fraction: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;78:1166-1187.
    >> Share

    August 2021
  259. FUDIM M, Abraham WT, von Bardeleben RS, Lindenfeld J, et al
    Device Therapy in Chronic Heart Failure: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;78:931-956.
    >> Share

  260. PAGANI FD
    Is Durable Left Ventricular Assist Device Therapy a Viable Option for the Elderly?
    J Am Coll Cardiol. 2021;78:895-897.
    >> Share

  261. EMERSON D, Chikwe J, Catarino P, Hassanein M, et al
    Contemporary Left Ventricular Assist Device Outcomes in an Aging Population: An STS INTERMACS Analysis.
    J Am Coll Cardiol. 2021;78:883-894.
    >> Share

  262. HERSBERGER L, Stanga Z, Schuetz P
    Reply: The Importance of Objective Nutritional Indexes in Heart Failure Patients.
    J Am Coll Cardiol. 2021;78:856-857.
    >> Share

  263. IKOMA T, Saito H, Oka T, Maekawa Y, et al
    The Importance of Objective Nutritional Indexes in Heart Failure Patients.
    J Am Coll Cardiol. 2021;78:855-856.
    >> Share

  264. DROZD M, Cubbon RM
    Infection and Adverse Outcomes in People With Chronic Heart Failure: Highlighting a Neglected Problem.
    J Am Coll Cardiol. 2021;78:760.
    >> Share

  265. SHEN L, Jhund PS, McMurray JJV
    Reply: Pneumonia and the Bigger Picture of Infection in Heart Failure.
    J Am Coll Cardiol. 2021;78:760-761.
    >> Share

  266. MEWTON N, Baudry G, Sebbag L
    Pneumonia in Chronic Heart Failure: What About a Full Picture of the Puzzle?
    J Am Coll Cardiol. 2021;78:759.
    >> Share

  267. LEWANDOWSKI AJ, Raman B, Bertagnolli M, Mohamed A, et al
    Association of Preterm Birth With Myocardial Fibrosis and Diastolic Dysfunction in Young Adulthood.
    J Am Coll Cardiol. 2021;78:683-692.
    >> Share

  268. CASAS G, Limeres J, Oristrell G, Gutierrez-Garcia L, et al
    Clinical Risk Prediction in Patients With Left Ventricular Myocardial Noncompaction.
    J Am Coll Cardiol. 2021;78:643-662.
    >> Share

  269. BROCH K, Anstensrud AK, Woxholt S, Andersen GO, et al
    Reply: Clarification Regarding the Lack of Heart Failure Events in the ASSAIL-MI Trial.
    J Am Coll Cardiol. 2021;78:637-638.
    >> Share

  270. DEL BUONO MG, Van Tassell BW, Abbate A
    Clarification Regarding the Lack of Heart Failure Events in the ASSAIL-MI Trial.
    J Am Coll Cardiol. 2021;78:637.
    >> Share

  271. PAVO N, Prausmuller S, Bartko PE, Goliasch G, et al
    Reply: Myocardial Angiotensin Relationships in Heart Failure: Long Way Beyond, Long Way Ahead.
    J Am Coll Cardiol. 2021;78:543-544.
    >> Share

  272. SHCHENDRYGINA A, Mewton N, Meznar AZ
    Advanced Heart Failure and Angiotensin System Fascinating Complexities.
    J Am Coll Cardiol. 2021;78:541-542.
    >> Share

  273. LI L, Wang J, Zhao G, Topaz S, et al
    Percutaneous DLC-Based Total Cavopulmonary Assist Achieves 96-Hour Survival in Lethal Cavopulmonary Failure Sheep.
    J Am Coll Cardiol. 2021;78:538-540.
    >> Share

    July 2021
  274. ROSSIGNOL P, Pitt B
    Heart Failure and Chronic Kidney Disease Patients: First It Is Necessary to Act.
    J Am Coll Cardiol. 2021;78:344-347.
    >> Share

  275. ITKIN M, Rockson SG, Burkhoff D
    Pathophysiology of the Lymphatic System in Patients With Heart Failure: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;78:278-290.
    >> Share

  276. AMUNDSEN BH
    Atrial Strain: A Piece of the HFpEF Puzzle Found, But Not Yet in Place.
    J Am Coll Cardiol. 2021;78:258-259.
    >> Share

  277. TEERLINK JR, Diaz R, Felker GM, McMurray JJV, et al
    Effect of Ejection Fraction on Clinical Outcomes in Patients Treated With Omecamtiv Mecarbil in GALACTIC-HF.
    J Am Coll Cardiol. 2021;78:97-108.
    >> Share

  278. FUDIM M, Salah HM, Sathananthan J, Bernier M, et al
    Lymphatic Dysregulation in Patients With Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2021;78:66-76.
    >> Share

  279. FUSTER JJ
    Clonal Hematopoiesis and Incident Heart Failure Risk: The Clone Wars Reach the Myocardium.
    J Am Coll Cardiol. 2021;78:53-55.
    >> Share

  280. YU B, Roberts MB, Raffield LM, Zekavat SM, et al
    Supplemental Association of Clonal Hematopoiesis With Incident Heart Failure.
    J Am Coll Cardiol. 2021;78:42-52.
    >> Share

  281. EIKELBOOM JW, Bhatt DL, Fox KAA, Bosch J, et al
    Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease.
    J Am Coll Cardiol. 2021;78:14-23.
    >> Share

    June 2021
  282. LAM CSP, Solomon SD
    Classification of Heart Failure According to Ejection Fraction: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2021;77:3217-3225.
    >> Share

  283. CONDORELLI G, Ferrante G
    MicroRNA-132 Inhibition Prevents Myocardial Hypertrophy and Heart Failure in Pigs: Making Sense Out of Antisense.
    J Am Coll Cardiol. 2021;77:2936-2938.
    >> Share

  284. HINKEL R, Batkai S, Bahr A, Bozoglu T, et al
    AntimiR-132 Attenuates Myocardial Hypertrophy in an Animal Model of Percutaneous Aortic Constriction.
    J Am Coll Cardiol. 2021;77:2923-2935.
    >> Share

  285. JEAN G, Van Mieghem NM, Gegenava T, van Gils L, et al
    Moderate Aortic Stenosis in Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2021;77:2796-2803.
    >> Share

  286. KENCHAIAH S, Ding J, Carr JJ, Allison MA, et al
    Pericardial Fat and the Risk of Heart Failure.
    J Am Coll Cardiol. 2021;77:2638-2652.
    >> Share

    May 2021
  287. PARIKH PB, Bhatt DL, Bhasin V, Anker SD, et al
    Impact of Percutaneous Coronary Intervention on Outcomes in Patients With Heart Failure: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:2432-2447.
    >> Share

  288. GOTTLIEB SH
    Food and Pharma: Linking 2 Silos of Heart Failure Research and Therapy.
    J Am Coll Cardiol. 2021;77:2320-2322.
    >> Share

  289. HERSBERGER L, Dietz A, Burgler H, Bargetzi A, et al
    Individualized Nutritional Support for Hospitalized Patients With Chronic Heart Failure.
    J Am Coll Cardiol. 2021;77:2307-2319.
    >> Share

  290. ALVAREZ-GARCIA J, Jaladanki S, Rivas-Lasarte M, Cagliostro M, et al
    New Heart Failure Diagnoses Among Patients Hospitalized for COVID-19.
    J Am Coll Cardiol. 2021;77:2260-2262.
    >> Share

  291. PATEL RB, Fonarow GC, Greene SJ, Zhang S, et al
    Kidney Function and Outcomes in Patients Hospitalized with Heart Failure.
    J Am Coll Cardiol. 2021 May 4. pii: S0735-1097(21)04968.
    >> Share

    April 2021
  292. MANCINI D, Gibson GT
    Impact of Pneumonia in Heart Failure Patients.
    J Am Coll Cardiol. 2021;77:1974-1976.
    >> Share

  293. SHEN L, Jhund PS, Anand IS, Bhatt AS, et al
    Incidence and Outcomes of Pneumonia in Patients With Heart Failure.
    J Am Coll Cardiol. 2021;77:1961-1973.
    >> Share

  294. HONKA H, Solis-Herrera C, Triplitt C, Norton L, et al
    Therapeutic Manipulation of Myocardial Metabolism: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:2022-2039.
    >> Share

  295. FUDIM M, Neuzil P, Malek F, Engelman ZJ, et al
    Greater Splanchnic Nerve Stimulation in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2021;77:1952-1953.
    >> Share

  296. SELVARAJ S, Claggett B, Minamisawa M, Windham BG, et al
    Atrial Fibrillation and Ischemic Stroke with the Amyloidogenic V122I Transthyretin Variant among Black Americans.
    J Am Coll Cardiol. 2021 Apr 19. pii: S0735-1097(21)04808.
    >> Share

  297. RAUH MJ
    Impact of Clonal Hematopoiesis in Ischemic and Nonischemic Heart Failure.
    J Am Coll Cardiol. 2021;77:1760-1762.
    >> Share

  298. PASCUAL-FIGAL DA, Bayes-Genis A, Diez-Diez M, Hernandez-Vicente A, et al
    Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction.
    J Am Coll Cardiol. 2021;77:1747-1759.
    >> Share

  299. PAVO N, Prausmuller S, Spinka G, Goliasch G, et al
    Myocardial Angiotensin Metabolism in End-Stage Heart Failure.
    J Am Coll Cardiol. 2021;77:1731-1743.
    >> Share

  300. YAFASOVA A, Fosbol EL, Schou M, Baslund B, et al
    Long-Term Cardiovascular Outcomes in Systemic Lupus Erythematosus.
    J Am Coll Cardiol. 2021;77:1717-1727.
    >> Share

    March 2021
  301. BOZKURT B, Fonarow GC, Goldberg LR, Guglin M, et al
    Cardiac Rehabilitation for Patients With Heart Failure: JACC Expert Panel.
    J Am Coll Cardiol. 2021;77:1454-1469.
    >> Share

  302. GREENE SJ, Khan MS
    Quadruple Medical Therapy for Heart Failure: Medications Working Together to Provide the Best Care.
    J Am Coll Cardiol. 2021;77:1408-1411.
    >> Share

  303. FERREIRA JP, Zannad F, Pocock SJ, Anker SD, et al
    Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure: EMPEROR-Reduced.
    J Am Coll Cardiol. 2021;77:1397-1407.
    >> Share

  304. KOSIBOROD MN, Vaduganathan M
    SGLT-2 Inhibitors in Heart Failure: Volume or Value?
    J Am Coll Cardiol. 2021;77:1393-1396.
    >> Share

  305. PACKER M, Anker SD, Butler J, Filippatos G, et al
    Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload: EMPEROR-Reduced Trial.
    J Am Coll Cardiol. 2021;77:1381-1392.
    >> Share

  306. VANDERHEYDEN M, Bartunek J, Neskovic AN, Milicic D, et al
    TRVD Therapy in Acute HF: Proof of Concept in Animal Model and Initial Clinical Experience.
    J Am Coll Cardiol. 2021;77:1481-1483.
    >> Share

  307. CHENG RK, Mooney DM, Chien CV, Shah KS, et al
    SGLT2 Inhibitors: Who Should Prescribe Them for Patients With Heart Failure?
    J Am Coll Cardiol. 2021;77:1375-1377.
    >> Share

  308. MCCULLOUGH PA, Rahimi G, Tecson KM
    Ambulatory Worsening of Renal Function in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2021;77:1222-1224.
    >> Share

  309. BELDHUIS IE, Myhre PL, Bristow M, Claggett B, et al
    Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function.
    J Am Coll Cardiol. 2021;77:1211-1221.
    >> Share

  310. BALTHAZAR T, Vandenbriele C, Verbrugge FH, Den Uil C, et al
    Managing Patients With Short-Term Mechanical Circulatory Support: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2021;77:1243-1256.
    >> Share

  311. MACK MJ, Lindenfeld J, Abraham WT, Kar S, et al
    3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure.
    J Am Coll Cardiol. 2021;77:1029-1040.
    >> Share

  312. KOFOED KF, Engstrom T, Sigvardsen PE, Linde JJ, et al
    Prognostic Value of Coronary CT Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes.
    J Am Coll Cardiol. 2021;77:1044-1052.
    >> Share

    February 2021
  313. GREENE SJ, Triana TS, Ionescu-Ittu R, Shi S, et al
    Patients Hospitalized for De Novo Versus Worsening Chronic Heart Failure in the United States.
    J Am Coll Cardiol. 2021;77:1023-1025.
    >> Share

  314. FELKER GM, Greene SJ
    Improving In-Hospital Diuretic Therapy for Heart Failure: The Need for High-Quality Evidence.
    J Am Coll Cardiol. 2021;77:709-712.
    >> Share

  315. RAO VS, Ivey-Miranda JB, Cox ZL, Riello R, et al
    Natriuretic Equation to Predict Loop Diuretic Response in Patients With Heart Failure.
    J Am Coll Cardiol. 2021;77:695-708.
    >> Share

  316. BERTRAND PB, Overbey JR, Zeng X, Levine RA, et al
    Progression of Tricuspid Regurgitation After Surgery for Ischemic Mitral Regurgitation.
    J Am Coll Cardiol. 2021;77:713-724.
    >> Share

  317. GOODLIN SJ
    RESPONSE: Comprehensive Training for Heart Failure Clinicians: The Integration of Palliative Care.
    J Am Coll Cardiol. 2021;77:504-505.
    >> Share

  318. CHUZI S, Khan SS, Pak ES
    Primary Palliative Care Education in Advanced Heart Failure and Transplantation Cardiology Fellowships.
    J Am Coll Cardiol. 2021;77:501-505.
    >> Share

  319. FRISK M, Le C, Shen X, Roe AT, et al
    Etiology-Dependent Impairment of Diastolic Cardiomyocyte Calcium Homeostasis in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2021;77:405-419.
    >> Share

  320. HULOT JS, Livrozet M
    HFpEF: Should We Consider Diabetic Patients Separately?: The Cardiomyocytes Say Yes.
    J Am Coll Cardiol. 2021;77:420-422.
    >> Share

    January 2021
  321. GOLDBERG LR
    The Pleiotropic Effects of SGLT2 Inhibitors: Remodeling the Treatment of Heart Failure.
    J Am Coll Cardiol. 2021;77:256-258.
    >> Share

  322. WU J, Mamas MA, de Belder MA, Deanfield JE, et al
    Second Decline in Admissions With Heart Failure and Myocardial Infarction During the COVID-19 Pandemic.
    J Am Coll Cardiol. 2021 Jan 12. pii: S0735-1097(20)38196.
    >> Share

  323. MADDOX TM, Januzzi JL Jr, Allen LA, Breathett K, et al
    2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Ove
    J Am Coll Cardiol. 2021 Jan 4. pii: S0735-1097(20)37867.
    >> Share

    December 2020
  324. PAGANI FD
    Extracorporeal Membrane Oxygenation Bridge to Durable Mechanical Circulatory Support: Discerning Futility From Heroic Therapy.
    J Am Coll Cardiol. 2020;76:2965-2967.
    >> Share

  325. ONG G, Pibarot P, Redfors B, Weissman NJ, et al
    Diastolic Function and Clinical Outcomes After Transcatheter Aortic Valve Replacement: PARTNER 2 SAPIEN 3 Registry.
    J Am Coll Cardiol. 2020;76:2940-2951.
    >> Share

  326. ALAHMAD B, Khraishah H
    Unconventional Natural Gas Development and Heart Failure: Accumulating Epidemiological Evidence.
    J Am Coll Cardiol. 2020;76:2875-2877.
    >> Share

  327. MCALEXANDER TP, Bandeen-Roche K, Buckley JP, Pollak J, et al
    Unconventional Natural Gas Development and Hospitalization for Heart Failure in Pennsylvania.
    J Am Coll Cardiol. 2020;76:2862-2874.
    >> Share

  328. GUPTA DK, Crescenzi R, Aday AW
    Unpreserved Lymphatic Reserve in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2020;76:2830-2833.
    >> Share

  329. ROSSITTO G, Mary S, McAllister C, Neves KB, et al
    Reduced Lymphatic Reserve in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2020;76:2817-2829.
    >> Share

  330. JANUZZI JL JR, Ibrahim NE
    Understanding the Mechanistic Benefit of Heart Failure Drugs Matters.
    J Am Coll Cardiol. 2020;76:2752-2754.
    >> Share

  331. OMAR M, Jensen J, Frederiksen PH, Kistorp C, et al
    Effect of Empagliflozin on Hemodynamics in Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2020;76:2740-2751.
    >> Share

  332. MARON BA, Kovacs G, Vaidya A, Bhatt DL, et al
    Cardiopulmonary Hemodynamics in Pulmonary Hypertension and Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2020;76:2671-2681.
    >> Share

  333. BEN-YEHUDA O, Shahim B, Chen S, Liu M, et al
    Pulmonary Hypertension in Transcatheter Mitral Valve Repair for Secondary Mitral Regurgitation: The COAPT Trial.
    J Am Coll Cardiol. 2020;76:2595-2606.
    >> Share

    November 2020
  334. BOZKURT B, Hershberger RE, Butler J, Isler ML, et al
    2021 ACC/AHA Key Data Elements and Definitions for Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Heart Failure).
    J Am Coll Cardiol. 2020 Nov 26. pii: S0735-1097(20)37777.
    >> Share

  335. ALVAREZ-GARCIA J, Lee S, Gupta A, Cagliostro M, et al
    Prognostic Impact of Prior Heart Failure in Patients Hospitalized With COVID-19.
    J Am Coll Cardiol. 2020;76:2334-2348.
    >> Share

  336. FASELIS C, Fonarow GC, Ahmed A
    Reply: Diuretics After Heart Failure Hospitalization, Not for All!
    J Am Coll Cardiol. 2020;76:2418-2420.
    >> Share

  337. DAUW J, Mullens W
    Diuretics After Heart Failure Hospitalization, Not for All!
    J Am Coll Cardiol. 2020;76:2418.
    >> Share

  338. PANJRATH GS, Krepp J
    COVID-19 and Heart Failure: Harsh Reality of Pre-Existing Conditions.
    J Am Coll Cardiol. 2020;76:2349-2351.
    >> Share

  339. CUNNINGHAM JW, Claggett BL, Solomon SD, Zile MR, et al
    Reply: Circulating Biomarkers Specific to Myocardial Extracellular Matrix Are Required to Embrace the Heterogeneity of HFpEF.
    J Am Coll Cardiol. 2020;76:2417-2418.
    >> Share

  340. LEWIS GA, Schelbert EB, Kadler KE, Miller CA, et al
    Circulating Biomarkers Specific to Myocardial Extracellular Matrix Are Required to Embrace the Heterogeneity of HFpEF.
    J Am Coll Cardiol. 2020;76:2416-2417.
    >> Share

  341. SANTOS-GALLEGO CG, Vargas-Delgado AP, Requena JA, Garcia-Ropero A, et al
    Randomized Trial of Empagliflozin in Non-Diabetic Patients with Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2020 Nov 9. pii: S0735-1097(20)37753.
    >> Share

  342. VELAZQUEZ EJ, Reinhardt SW
    Limitations of Natriuretic Peptide Levels in Establishing SGLT-2 Inhibitors for Heart Failure Care.
    J Am Coll Cardiol. 2020;76:2086-2088.
    >> Share

    October 2020
  343. GIANNONI A, Gentile F, Sciarrone P, Emdin M, et al
    Reply: Upright Cheyne-Stokes Respiration in Heart Failure: An Ominous Sign of Cardiovascular Dysregulation.
    J Am Coll Cardiol. 2020;76:2040-2041.
    >> Share

  344. FUDIM M, Soloveva A
    Upright Cheyne-Stokes Respiration in Heart Failure: An Ominous Sign of Cardiovascular Dysregulation.
    J Am Coll Cardiol. 2020;76:2038-2039.
    >> Share

  345. LIU PP, Al-Khalaf M, Blet A
    Time to Reframe Ejection Fraction in Light of New Pathophysiological Insights Into Heart Failure.
    J Am Coll Cardiol. 2020;76:1995-1998.
    >> Share

  346. ADAMO L, Yu J, Rocha-Resende C, Javaheri A, et al
    Proteomic Signatures of Heart Failure in Relation to Left Ventricular Ejection Fraction.
    J Am Coll Cardiol. 2020;76:1982-1994.
    >> Share

  347. WHITELAW S, Thabane L, Mamas MA, Reza N, et al
    Characteristics of Heart Failure Trials Associated With Under-Representation of Women as Lead Authors.
    J Am Coll Cardiol. 2020;76:1919-1930.
    >> Share

  348. HEIDENREICH PA, Fonarow GC, Breathett K, Jurgens CY, et al
    2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
    J Am Coll Cardiol. 2020 Oct 27. pii: S0735-1097(20)35968.
    >> Share

  349. KITTLESON MM
    The Trials of Women in Cardiology.
    J Am Coll Cardiol. 2020;76:1931-1933.
    >> Share

  350. EMDIN M, Aimo A, Castiglione V, Vergaro G, et al
    Targeting Cyclic Guanosine Monophosphate to Treat Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2020;76:1795-1807.
    >> Share

  351. PSOTKA MA, Fiuzat M, Metra M, O'Connor CM, et al
    Reply: Potential Mechanisms to Improve Heart Failure Clinical Trial Publication Rates.
    J Am Coll Cardiol. 2020;76:1717-1718.
    >> Share

  352. MEWTON N, Sebbag L, Bochaton T
    Other Things Behind the Low Rate of Heart Failure Trial Publication.
    J Am Coll Cardiol. 2020;76:1716-1717.
    >> Share

  353. MEHMOOD M
    Low Publication Rates of Heart Failure Clinical Trials: Finding Success in Failure.
    J Am Coll Cardiol. 2020;76:1715-1716.
    >> Share

    September 2020
  354. KHATANA SAM, Grandin EW, Rame JE, Shen C, et al
    Medicaid Expansion and Ventricular Assist Device Implantation: An Analysis of the INTERMACS Registry.
    J Am Coll Cardiol. 2020;76:1501-1502.
    >> Share

  355. HAHN RT, Asch F, Weissman NJ, Grayburn P, et al
    Impact of Tricuspid Regurgitation on Clinical Outcomes: The COAPT Trial.
    J Am Coll Cardiol. 2020;76:1305-1314.
    >> Share

  356. GOTTLIEB SS, Ahmed T
    Consider Everything When Prescribing Sacubitril/Valsartan: Perfection Is the Enemy of Good.
    J Am Coll Cardiol. 2020;76:1049-1050.
    >> Share

  357. GUAZZI M, Ghio S, Adir Y
    Pulmonary Hypertension in HFpEF and HFrEF: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2020;76:1102-1111.
    >> Share

  358. JENTZER JC, Bihorac A, Brusca SB, Del Rio-Pertuz G, et al
    Contemporary Management of Severe Acute Kidney Injury and Refractory Cardiorenal Syndrome: JACC Council Perspectives.
    J Am Coll Cardiol. 2020;76:1084-1101.
    >> Share

    August 2020
  359. KAGIYAMA N, Piccirilli M, Yanamala N, Shrestha S, et al
    Machine Learning Assessment of Left Ventricular Diastolic Function Based on Electrocardiographic Features.
    J Am Coll Cardiol. 2020;76:930-941.
    >> Share

  360. YAFASOVA A, Fosbol EL, Schou M, Gustafsson F, et al
    Long-Term Adverse Cardiac Outcomes in Patients With Sarcoidosis.
    J Am Coll Cardiol. 2020;76:767-777.
    >> Share

  361. COX ZL, Stevenson LW
    The Weight of Evidence for Diuretics and Parachutes.
    J Am Coll Cardiol. 2020;76:680-683.
    >> Share

  362. BAYES-GENIS A, Nunez J, Lupon J
    Sacubitril/Valsartan as Antifibrotic Drug: Rejuvenating the Fibrosed HFpEF Heart.
    J Am Coll Cardiol. 2020;76:515-517.
    >> Share

  363. CUNNINGHAM JW, Claggett BL, O'Meara E, Prescott MF, et al
    Effect of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFpEF.
    J Am Coll Cardiol. 2020;76:503-514.
    >> Share

    July 2020
  364. POOLE JE, Olshansky B, Mark DB, Anderson J, et al
    Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFT.
    J Am Coll Cardiol. 2020;76:405-415.
    >> Share

  365. JANUZZI JL JR, Ibrahim NE
    The Need to Innovate and Accelerate Clinical Trial Performance: BeAT the Clock.
    J Am Coll Cardiol. 2020;76:14-16.
    >> Share

    June 2020
  366. MEHRA MR, Grazette LP
    Untimely Trial Publication: A Sin of Omission?
    J Am Coll Cardiol. 2020;75:3162-3163.
    >> Share

  367. ROWIN EJ, Maron BJ, Carrick RT, Patel PP, et al
    Outcomes in Patients With Hypertrophic Cardiomyopathy and Left Ventricular Systolic Dysfunction.
    J Am Coll Cardiol. 2020;75:3033-3043.
    >> Share

  368. PARKER WF, Chung K, Anderson AS, Siegler M, et al
    Practice Changes at U.S. Transplant Centers After the New Adult Heart Allocation Policy.
    J Am Coll Cardiol. 2020;75:2906-2916.
    >> Share

  369. HANNA M, Ruberg FL, Maurer MS, Dispenzieri A, et al
    Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2020;75:2851-2862.
    >> Share

    May 2020
  370. YITSHAK-SADE M, Nethery R, Abu Awad Y, Mealli F, et al
    Lowering Air Pollution Levels in Massachusetts May Prevent Cardiovascular Hospital Admissions.
    J Am Coll Cardiol. 2020;75:2642-2644.
    >> Share

  371. MEINERTZ T, Munzel T
    Kansas City Cardiomyopathy Quality Score Indicates Sustained Health Status Improvement in Patients After TMVr.
    J Am Coll Cardiol. 2020;75:2107-2109.
    >> Share

    April 2020
  372. REDFORS B, Furer A, Selker HP, Thiele H, et al
    Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI.
    J Am Coll Cardiol. 2020;75:1743-1754.
    >> Share

    March 2020
  373. SHAH AM, Cikes M, Zile MR, McMurray JJV, et al
    Reply: Different Phenotype Characterization in PARAGON-HF: An Unresolved Puzzle in Patients With HFpEF.
    J Am Coll Cardiol. 2020;75:1501-1502.
    >> Share

  374. PALAZZUOLI A, Ruocco G
    Different Phenotype Characterization in PARAGON-HF: An Unresolved Puzzle in Patients With HFpEF.
    J Am Coll Cardiol. 2020;75:1500-1501.
    >> Share

  375. GUGLIN M, Zucker MJ, Borlaug BA, Breen E, et al
    Evaluation for Heart Transplantation and LVAD Implantation: JACC Council Perspectives.
    J Am Coll Cardiol. 2020;75:1471-1487.
    >> Share

  376. NIJST P, Martens P, Dauw J, Tang WHW, et al
    Withdrawal of Neurohumoral Blockade After Cardiac Resynchronization Therapy.
    J Am Coll Cardiol. 2020;75:1426-1438.
    >> Share

  377. KITZMAN DW, Upadhya B, Felker GM
    A Biomarker Approach to Understanding HFpEF.
    J Am Coll Cardiol. 2020;75:1296-1298.
    >> Share

  378. MARFELLA R, Amarelli C, Cacciatore F, Balestrieri ML, et al
    Lipid Accumulation in Hearts Transplanted From Nondiabetic Donors to Diabetic Recipients.
    J Am Coll Cardiol. 2020;75:1249-1262.
    >> Share

  379. NAMBIAR L, LeWinter MM, VanBuren PC, Dauerman HL, et al
    Decade Long Temporal Trends in U.S. Hypertension Related Cardiovascular Mortality.
    J Am Coll Cardiol. 2020 Mar 13. pii: S0735-1097(20)34531.
    >> Share

  380. SABBATINI AR, Kararigas G
    Menopause-Related Estrogen Decrease and the Pathogenesis of HFpEF: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2020;75:1074-1082.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016